Evaluation of Geisinger at Home (GaH) Patient Management

NCT04547374 | Withdrawn

• 1 other identifier: 2020-0769
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

Healthcare cost has increased drastically in the last decade, and over 50% of the cost can be attributed to a small portion (5-10%) of the population. Certain clinical programs, such as home-based care, aim to reduce this utilization but need methods to identify the most appropriate patients to enroll. The Investigators believe that data-driven approaches can optimize this new healthcare delivery system to target patients who may likely benefit from the program. The primary aim of this project is to determine the effectiveness of the Geisinger at Home ™ (GaH) program on survival, emergency department (ED) visits and hospitalizations in multiple patient populations defined by clinical characteristics.

Conditions

Population Health Management

Keywords

Machine Learning; Supervised Machine Learning

Outcome Measures

Primary Outcomes (1)

• Hospital Visits and Admissions

  The primary outcomes of number of IP admission and number of ED visits through 6 months post-enrollment will be compared between groups.

  6 months

Study Arms (2)

Cohort 1 - GaH Intervention

Cohort 1 - GaH intervention group

Other: GaH Intervention

Cohort 2 - Standard-of-care control group

Cohort 2 - Standard-of-care control group \*Importantly, these individuals are eligible for referral to GaH at the discretion of their physicians.\*

Interventions

GaH Intervention OTHER

Patients in this cohort will be referred for management/intervention with GaH. However, the purpose of this program is not to define, control, or evaluate the specific details of the GaH process or procedure, but to evaluate its effectiveness as an alternative clinical care path in this setting. As such, the specific details and actions of the GaH care team in each patient interaction are left to their medical discretion.

Cohort 1 - GaH Intervention

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

All adult Geisinger patients (≥18 years of age) eligible for enrollment into Geisinger at Home (TM) (GaH).

You may qualify if:

• All adult Geisinger patients (≥18 years of age) eligible for enrollment into GaH.

You may not qualify if:

• Patients not eligible for enrollment into GaH

Sponsors & Collaborators

• Geisinger Clinic: lead

Study Sites (1)

Geisinger

Danville, Pennsylvania, 17822, United States

Location

Study Officials

• Brandon K Fornwalt, MD,Phd

  Geisinger Clinic

  PRINCIPAL INVESTIGATOR

• H. Lester Kirchner, PhD

  Geisinger Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 4, 2020
• First Posted: September 14, 2020
• Study Start: April 1, 2021
• Primary Completion: July 12, 2021
• Study Completion: July 12, 2021
• Last Updated: October 19, 2023

Record last verified: 2023-10

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)